Eric Sherbet, Executive Vice President and General Counsel at IQVIA Holdings Inc. (), sold common stock totaling $1,245,800 on July 29, 2026.
The transaction involved the sale of 5,000 shares of IQVIA common stock at a price of $249.16 per share. Following this sale, Mr. Sherbet directly holds 20,999 shares of the company’s common stock. Mr. Sherbet’s title is listed as Executive Vice President, General Counsel.The sale comes as IQVIA stock trades near its 52-week high of $251.36, following a strong 13% return over the past week. According to InvestingPro analysis, the stock remains undervalued relative to its Fair Value, with shares currently trading at $235.02. The company maintains a “GOOD” financial health score, and InvestingPro offers 12 additional exclusive tips for IQV investors, along with comprehensive Pro Research Reports available for over 1,400 US equities.
In other recent news, IQVIA Holdings reported second-quarter adjusted earnings and revenue that surpassed Wall Street expectations. The company achieved an adjusted diluted earnings per share of $3.15, exceeding the analyst forecast of $3.04, and reported revenue of $4.37 billion, which was above the anticipated $4.30 billion. This performance was attributed to stronger organic growth and increased demand in its clinical and commercial sectors. Following these results, IQVIA raised its outlook for future quarters. Additionally, Truist Securities increased its price target for IQVIA shares to $300, citing the company’s second-quarter 2026 bookings trends and AI strategy as key factors. Stifel also raised its price target for the company to $276, highlighting improving end markets and IQVIA’s strengthening position within those markets. Both firms maintained a Buy rating on the stock. These developments reflect a positive sentiment among analysts regarding IQVIA’s future prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Source:
www.investing.com
